News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Insights
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
12,992 Results
Type
Article (1347)
Company Profile (5)
Press Release (11640)
Section
Business (3828)
Career Advice (6)
Deals (545)
Drug Delivery (10)
Drug Development (2890)
FDA (284)
Job Trends (335)
News (6361)
Policy (512)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (97)
Accelerated approval (4)
Allergies (1)
Alliances (1248)
ALS (15)
Alzheimer's disease (24)
Antibody-drug conjugate (ADC) (3)
Approvals (267)
Artificial intelligence (23)
ASCO (5)
Autoimmune disease (8)
Automation (2)
Bankruptcy (5)
Best Places to Work (300)
BIO (2)
Biologics (4)
Biosimilars (2)
BioSpace Insights (6)
Biotechnology (2)
Bispecific (1)
Bladder cancer (25)
Brain cancer (5)
Breast cancer (4)
Cancer (207)
Cardiovascular disease (12)
Career advice (6)
Career pathing (1)
CAR-T (75)
CDC (1)
CDMO (16)
Cell therapy (163)
Cervical cancer (1)
Clinical research (2080)
Collaboration (125)
Commercialization (1)
Company closure (1)
Compensation (19)
Complete response letters (2)
COVID-19 (211)
CRISPR (17)
C-suite (46)
Cystic fibrosis (17)
Data (378)
Denatured (1)
Dermatology (1)
Diabetes (21)
Diagnostics (84)
Drug discovery (12)
Drug pricing (2)
Duchenne muscular dystrophy (66)
Earnings (1177)
Editorial (5)
ESMO (12)
Events (2138)
Executive appointments (29)
Eye disease (1)
FDA (424)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (59)
Gene editing (34)
Generative AI (1)
Gene therapy (430)
GLP-1 (26)
Government (129)
Guidances (9)
Healthcare (327)
Hematology (5)
HIV (2)
Huntington's disease (4)
IgA nephropathy (2)
Immunology and inflammation (9)
Immuno-oncology (6)
Indications (3)
Infectious disease (236)
Inflation Reduction Act (1)
Influenza (8)
Intellectual property (13)
Interviews (4)
IPO (269)
IRA (1)
Job creations (43)
Job search strategy (3)
JPM (2)
Kidney disease (2)
Layoffs (18)
Leadership (1)
Legal (48)
Licensing (2)
Liver cancer (3)
Lung cancer (34)
Lymphoma (13)
Machine learning (2)
Manufacturing (159)
Marketing (1)
MASH (2)
Medical device (45)
Medtech (46)
Mergers & acquisitions (312)
Metabolic disorders (34)
mRNA (16)
Multiple sclerosis (2)
Multispecific (1)
Netherlands (1)
Neurodegenerative disease (28)
Neuroscience (77)
NextGen: Class of 2026 (148)
Non-profit (52)
Now hiring (3)
Obesity (7)
Opinion (16)
Ovarian cancer (25)
Pain (10)
Pancreatic cancer (2)
Parkinson's disease (7)
Partnered (2)
Patents (28)
Patient recruitment (40)
Peanut (1)
People (921)
Peptides (1)
Phase 1 (1181)
Phase 2 (1128)
Phase 3 (507)
Pipeline (406)
Policy (4)
Postmarket research (19)
Preclinical (495)
Press Release (13)
Prostate cancer (4)
Radiopharmaceuticals (13)
Rare diseases (122)
Real estate (122)
Regenerative medicine (1)
Regulatory (583)
Reports (1)
Research institute (74)
Resumes & cover letters (2)
Rett syndrome (12)
RNA editing (4)
RSV (5)
Schizophrenia (2)
Series A (12)
Series B (10)
Sickle cell disease (5)
Special edition (3)
Spinal muscular atrophy (12)
Sponsored (6)
Startups (95)
Stem cells (1)
Supply chain (2)
Tariffs (1)
The Weekly (3)
Vaccines (120)
Venture capital (3)
Wet AMD (2)
Women's health (1)
Date
Last 7 days (17)
Last 30 days (70)
Last 365 days (837)
2026 (711)
2025 (905)
2024 (986)
2023 (1170)
2022 (1576)
2021 (1576)
2020 (1204)
2019 (882)
2018 (559)
2017 (539)
2016 (397)
2015 (477)
2014 (266)
2013 (229)
2012 (192)
2011 (207)
2010 (192)
Location
Africa (13)
Arizona (2)
Arkansas (1)
Asia (601)
Australia (102)
California (451)
Canada (32)
China (45)
Colorado (6)
Connecticut (3)
Delaware (1)
Europe (2830)
Florida (28)
Georgia (13)
Idaho (1)
Illinois (17)
India (2)
Indiana (6)
Japan (22)
Kansas (5)
Kentucky (2)
Maine (1)
Maryland (54)
Massachusetts (288)
Michigan (3)
Minnesota (7)
Mississippi (1)
Missouri (1)
New Jersey (143)
New York (81)
North Carolina (75)
North Dakota (3)
Northern California (285)
Ohio (60)
Oklahoma (1)
Pennsylvania (113)
Puerto Rico (1)
South America (17)
Southern California (103)
Tennessee (7)
Texas (117)
United States (1520)
Utah (7)
Virginia (4)
Washington D.C. (7)
Washington State (75)
Wisconsin (12)
12,992 Results for "vect horus".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Vect-Horus Publication in Pharmaceutics Outlines How Vectors Can Improve Delivery of Therapeutics to Organs and Tumors
Vect-Horus announced the publication of a paper in the open-access scientific journal Pharmaceutics Vol 26.
April 22, 2024
·
2 min read
Business
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Pr. Xavier Declèves
VECT-HORUS today announced the appointment Pr. Xavier Declèves to its scientific advisory board (SAB).
January 11, 2024
·
2 min read
Press Releases
RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma
September 11, 2025
·
3 min read
Business
Vect-Horus Enters Exclusive License Agreement with Ionis Pharmaceuticals to Advance Systemic Delivery of RNA-Targeted Medicines for Neurological Diseases
Vect-Horus today announced it has entered into a global license agreement with Ionis Pharmaceuticals, Inc. (Nasdaq: IONS).
January 30, 2024
·
2 min read
Business
Vect-Horus Enters Exclusive License Agreement with Novo Nordisk to Develop Targeted Therapeutics
Vect-Horus, a privately held biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, today announced it has entered into a global license agreement with Novo Nordisk A/S.
October 30, 2023
·
2 min read
Business
Vect-Horus Appoints Dr Jean-Manuel Péan as Chief Scientific Officer
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, announced the appointment of Dr Jean-Manuel Péan as Chief Scientific Officer.
April 3, 2023
·
2 min read
Business
Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Frédéric Matonti, a Leading Ophthalmology Specialist
Vect-Horus announced the appointment of Pr. Frédéric Matonti to its scientific advisory board.
May 10, 2022
·
2 min read
Lone Star Bio
RadioMedix and Vect-Horus announce first dosing of Glioblastoma Multiforme and Pancreatic ductal adenocarcinoma patients with 68Ga-RMX-VH
RadioMedix and Vect-Horus are pleased to announce that they have successfully dosed the first patients in an exploratory Investigational New Drug (eIND) application to evaluate 68Ga-RMX-VH for the diagnostic of Glioblastoma Multiforme (GBM) and Pancreatic ductal adenocarcinoma (PDAC).
November 15, 2022
·
4 min read
Drug Development
VECT-HORUS and CERIMED Announce Collaboration to Support the Development of VECT-HORUS’ Theragnostic Agents
VECT-HORUS, a biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging agents, has announced the signing of a collaboration agreement with CERIMED (European Centre for Research in Medical Imaging) to support the preclinical development of VECT-HORUS’ theragnostic agents.
November 17, 2020
·
2 min read
Business
Vect-Horus and MDimune Collaborate to Develop a Novel Approach to CNS Drug Delivery Based on Vectorized Cell-derived Vesicles (CDVs)
MDimune Inc. and Vect-Horus are please to announce today the signing of a Research Collaboration Agreement.
September 7, 2021
·
4 min read
1 of 1,300
Next
